Sivarods 20small
Screen 20shot 202016 01 15 20at 2012.52.19 20pm

Siva Therapeutics Inc

We are developing a minimally invasive, highly effective cancer therapy that targets and destroys solid tumors, and stimulates the immune system, using heat.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Austin, TX, US
  • Currency USD
  • Founded October 2010
  • Employees 3
  • Incorporation Type C-corp
  • Website sivatherapeutics.com

Company Summary

Siva Therapeutics has a safe and effective approach to cancer treatment using nanotechnology to deliver heat - Targeted Hyperthermia - to solid tumors. Siva’s approach uses localized heating of tumors with polymer coated gold nanorods - SivaRods™ - and infrared light. Siva’s therapy has few side effects and promises to be more selective than chemotherapy, less destructive than radiation, and without the risks of surgical treatment.

Team

  • Len has 17 years of experience with commercialization of biotech products, services, and licensing, following an academic career as a professor of Bioengineering and Laboratory Medicine at the University of Washington. He has managed R&D and business development teams, and most recently managed P&L for a business unit of ThermoFisher Scientific that grew to $26M. An oncology drug project he led was partnered and is in the clinic.

  • 36a9d0f6 61d3 43f0 b339 7c11a5687927
    COO and Director of R&D

    Colin Shepherd, PhD, MBA, received a BS in Biotechnology from the University of Kentucky (2000), a PhD in Genetics from Iowa State University (2007), and an MBA from Iowa State University (2008). He founded AimsBio, Inc. in 2006 and commercialized a novel amino acid bioassay that was used by clients in a variety of industries. Recently, he performed as COO and CEO of PhylloTech LLC, where he led the overall business development and financial ope

  • Ec6a6917 05d7 4d51 8653 8d24c28b517d
    Chief Legal Officer

    Steve has practiced law for over 30 years in law firms and public and private corporations. He co-founded and served as Chief Legal Officer and Vice Chairman of ClearVision Laser Centers, which had a 12X exit for early investors. He is experienced in every aspect of early stage companies, and will be responsible for contracts, negotiations, licensing, and other legal issues. Steve received his JD degree from Harvard Law School.

Advisors

  • Default avatar
    Sheridan Ross PC
    Patent Lawyer
    Unconfirmed
    Default avatar
    Graham & Company, PC
    Accountant
    Unconfirmed
    Default avatar
    Bob Kline
    Board Member
    Unconfirmed
  • Default avatar
    Dr. Rene Gonzalez
    Unconfirmed
    Default avatar
    Dr. Mark Dewhirst
    Unconfirmed

Previous Investors

  • Default avatar
    Breakout Labs (Thiel Foundation)
    Unconfirmed
    Default avatar
    John Hennessey
    Angel Investor
    Unconfirmed
  • Default avatar
    Selz Foundation
    Angel Investor
    Unconfirmed